Sponsor or institution

Clinical trials and research at Bio-Path Holdings, Inc.

As of November 12, 2026, Find a Trial lists 3 clinical trials run by Bio-Path Holdings, Inc. that are recruiting, in United States. By phase: Phase 1 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
Evaluating BP1002 for patients with relapsed or refractory acute myeloid leukemia Phase 1 La Jolla, California and 3 other locations Recruiting Jan 13, 2022
Testing BP1001-A for advanced or recurrent solid tumors Phase 1 Silver Spring, Maryland and 3 other locations Recruiting Dec 12, 2019
Combination treatment for acute myeloid leukemia using BP1001, venetoclax, and decitabine Phase 2 Los Angeles, California and 8 other locations Recruiting May 25, 2016

All recruiting trials (3)

Quick answers

How many clinical trials run by Bio-Path Holdings, Inc. are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.